Early and Comprehensive Care Bundle in Elderly for Acute Heart Failure: a Stepped Wedge Cluster Randomized Trial (ELISABETH)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03683212 |
Recruitment Status :
Completed
First Posted : September 25, 2018
Last Update Posted : July 2, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Acute Heart Failure | Procedure: Early intensive care bundle | Not Applicable |
Acute heart failure (AHF) is one of the most common diagnoses for elderly patients in the emergency department (ED), with an admission rate higher than 80% and 1-month mortality around 10%. There is scarce evidence of any clinical added value of a specific treatment to improve outcomes, and European guidelines for the management of AHF are based on moderate levels of evidence, due to the lack of randomized controlled trials. Recent reports suggest that the very early administration of full recommended therapy may decrease mortality. However, several studies highlighted that elderly patients often received suboptimal treatment: For example, less than a third of them received nitrates therapy while it is recommended. Furthermore, a recent preliminary study reported that only 50% of them are assessed for precipitating factors - although it has been reported that precipitating factors are independently associated with mortality.
The hypothesis of the Elisabeth Study s is that an early care bundle that comprises early and comprehensive management of symptoms, along with prompt detection and treatment of precipitating factors should improve AHF outcome in elderly patients.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 503 participants |
Allocation: | Randomized |
Intervention Model: | Sequential Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Early and Comprehensive Care Bundle in Elderly for Acute Heart Failure: a Stepped Wedge Cluster Randomized Trial |
Actual Study Start Date : | December 10, 2018 |
Actual Primary Completion Date : | November 12, 2019 |
Actual Study Completion Date : | November 12, 2019 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention period : early and comprehensive care bundle |
Procedure: Early intensive care bundle
The care bundle comprises a list of items to follow and tick on a handover checklist within 4 hours of ED management:
|
No Intervention: acute heart failure standard therapy |
- Number of days alive and out of hospital [ Time Frame: 30 days ]Number of days alive and out of hospital
- To evaluate the effect of AHF management on the 30-day cardiovascular death [ Time Frame: 30 days ]cardiovascular death
- To evaluate the effect of AHF management on the 30-day all causes death [ Time Frame: 30 days ]all causes death
- To evaluate the effect of AHF management on the hospital readmission at 30 days [ Time Frame: 30 days ]hospital readmission
- To evaluate the effect of AHF management on the length of stay in hospital [ Time Frame: 30 days ]length of stay in hospital
- To evaluate the effect of AHF management on changes of more than 2 fold in creatinine level from randomization to day 30 or to discharge whichever comes first [ Time Frame: 30 days ]creatinine level

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 75 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
-
Patients aged 75 years and older admitted to the emergency department with a diagnosis of acute heart failure determined by the emergency physician, based on the presence of:
- at least one of the following symptoms : acute, or worsening of dyspnea, orthopnea
- one or more of the followings: pulmonary rales, peripheral edema, a chest radiograph or transthoracic echocardiography showing pulmonary vascular congestion signs, increased natriuretic peptides (BNP or NT-pro-BNP).
- Patients affiliated to French social security ("AME excepted")
- Written informed consent signed by the patient / the trustworthy person / family member / close relative, or inclusion in case of emergency and written informed consent will been signed by the patient (if need be by trustworthy person, family member or close relative) as soon as possible (article L1122-1-2 of the French Public Health Code)
Exclusion Criteria:
-
Patients are excluded if they have any of the followings:
- other obvious cause of acute illness (severe sepsis, ST elevation Myocardial infarction)
- systolic blood pressure less than 100 mmHg
- severe mitral or aortic stenosis, or severe aortic regurgitation
- known chronic kidney injury on dialysis
- shock from any cause
- Time from ED entrance to inclusion > 6h
- Patient under legal protection measure (tutorship or curatorship) and patient deprived of freedom

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03683212
France | |
Emergency department Hospital Pitié-Salpêtrière | |
Paris, France, 75013 |
Principal Investigator: | Yonathan Freund, Doctor | Assistance Publique - Hôpitaux de Paris |
Responsible Party: | Assistance Publique - Hôpitaux de Paris |
ClinicalTrials.gov Identifier: | NCT03683212 |
Other Study ID Numbers: |
K170918J 2018-A01139-46 ( Other Identifier: ANSM ) |
First Posted: | September 25, 2018 Key Record Dates |
Last Update Posted: | July 2, 2020 |
Last Verified: | June 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Emergency department Elderly Acute heart failure Pulmonary edema |
Heart Failure Heart Diseases Cardiovascular Diseases |